PMID- 7631849 OWN - NLM STAT- MEDLINE DCOM- 19950901 LR - 20171213 IS - 0002-9513 (Print) IS - 0002-9513 (Linking) VI - 269 IP - 1 Pt 2 DP - 1995 Jul TI - GTP requirement for isoproterenol activation of calcium channels in vascular myocytes. PG - H195-202 AB - The effects of activating the beta-adrenoceptor pathway on calcium current (ICa) in rabbit portal vein (PV) were studied in myocytes freshly isolated by collagenase and elastase treatment. ICa was measured at room temperature (20 degrees C) using whole cell, voltage-clamp methods from a holding potential of -60 mV in cells dialyzed with a pipette solution containing (mM) 100 CsCl, 20 tetraethylammonium chloride, 5 NaCl, 5 MgATP, 20 N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid (HEPES), and 10 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid (BAPTA). The cells were superfused with a solution containing (mM) 140 NaCl, 5 KCl, 1 MgCl2, 5 CaCl2, 10 HEPES, and 10 glucose. Only L-type ICa was present in these myocytes, averaging 3.5 +/- 0.3 pA/pF at +10 mV under control conditions. With 0.1 mM guanosine 5'-triphosphate (GTP) added to the pipette solution, 1 microM isoproterenol (Iso) or forskolin (Fsk) uniformly increased ICa: Iso by 45 +/- 5% and Fsk by 88 +/- 11%. This augmentation of ICa was not associated with significant changes in the voltage dependence of activation or inactivation but was associated with a small increase in the rate of inactivation of ICa. Fsk was also associated with an increased rate of ICa activation. The Iso effect was blocked by pretreatment with 1 microM propranolol and reversed by propranolol after Iso exposure. The ICa response to 10 microM Iso or Fsk was smaller than the response to 1 microM, with some cells showing a steady-state reduction in ICa. When the latter occurred, the voltage dependence of availability was shifted to the left by 5 +/- 0.4 mV.(ABSTRACT TRUNCATED AT 250 WORDS) FAU - Shi, Q Y AU - Shi QY AD - Bockus Research Institute, Graduate Hospital, University of Pennsylvania, Philadelphia 19146, USA. FAU - Cox, R H AU - Cox RH LA - eng GR - HL-28476/HL/NHLBI NIH HHS/United States PT - Journal Article PT - Research Support, Non-U.S. Gov't PT - Research Support, U.S. Gov't, P.H.S. PL - United States TA - Am J Physiol JT - The American journal of physiology JID - 0370511 RN - 0 (Calcium Channels) RN - 0 (Thionucleotides) RN - 146-91-8 (Guanosine Diphosphate) RN - 1F7A44V6OU (Colforsin) RN - 37589-80-3 (Guanosine 5'-O-(3-Thiotriphosphate)) RN - 71376-97-1 (guanosine 5'-O-(2-thiodiphosphate)) RN - 86-01-1 (Guanosine Triphosphate) RN - L628TT009W (Isoproterenol) SB - IM MH - Animals MH - Calcium Channels/*drug effects/physiology MH - Colforsin/pharmacology MH - Guanosine 5'-O-(3-Thiotriphosphate)/pharmacology MH - Guanosine Diphosphate/analogs & derivatives/pharmacology MH - Guanosine Triphosphate/*pharmacology MH - Isoproterenol/antagonists & inhibitors/*pharmacology MH - Male MH - Muscle, Smooth, Vascular/*metabolism MH - Patch-Clamp Techniques MH - Rabbits MH - Thionucleotides/pharmacology EDAT- 1995/07/01 00:00 MHDA- 1995/07/01 00:01 CRDT- 1995/07/01 00:00 PHST- 1995/07/01 00:00 [pubmed] PHST- 1995/07/01 00:01 [medline] PHST- 1995/07/01 00:00 [entrez] AID - 10.1152/ajpheart.1995.269.1.H195 [doi] PST - ppublish SO - Am J Physiol. 1995 Jul;269(1 Pt 2):H195-202. doi: 10.1152/ajpheart.1995.269.1.H195.